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Abstract
Background: Disparities in health status occur between people with differing socioeconomic status and disadvantaged
groups usually have the highest risk exposure and the worst health outcome. We sought to examine the social disparities
in the population prevalence of diabetes and in the development of treated end stage renal disease due to type 1
diabetes which has not previously been studied in Australia and New Zealand in isolation from type 2 diabetes.
Methods: This observational study examined the population prevalence of diabetes in a sample of the Australian
population (7,434,492) using data from the National Diabetes Services Scheme and of treated end stage renal disease
due to diabetes using data from the Australian and New Zealand Dialysis and Transplant Registry. The data were then
correlated with the Australian Bureau of Statistics Socioeconomic Indexes for Areas for an examination of
socioeconomic disparities.
Results: There is a social gradient in the prevalence of diabetes in Australia with disease incidence decreasing
incrementally with increasing affluence (Spearman’s rho = .765 p < 0.001). There is a higher risk of developing end
stage renal disease due to type 1 diabetes for males with low socioeconomic status (RR 1.20; CI 1.002–1.459) in
comparison to females with low socioeconomic status. In Australia and New Zealand Aboriginal and Torres Strait
Islanders, Maori and Pacific Islanders appear to have a low risk of end stage renal disease due to type 1 diabetes but
continue to carry a vastly disproportionate burden of end stage renal disease due to type 2 diabetes (RR 6.57 CI 6.04–
7.14 & 6.48 CI 6.02–6.97 respectively p < 0.001) in comparison to other Australian and New Zealanders.
Conclusion: Whilst low socioeconomic status is associated with a higher prevalence of diabetes the inverse social
gradient seen in this study has not previously been reported. The social disparity seen in relation to treated end stage
renal disease due to type 2 diabetes for Aboriginal and Torres Strait Islanders, Maori and Pacific Islanders has changed
very little in the past 20 years. Addressing the increasing incidence of diabetes in Australia requires consideration of the
underlying social determinants of health.
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Background
Over one million Australians are living with diabetes
and 10% of these have type 1 diabetes mellitus (T1DM).
The childhood incidence rate of T1DM in Australia
(22.5 per 100,000 population) is one of the highest in the
world [1] and sits in the top 10 of countries compared
across the globe [2]. The population prevalence of
type 2 diabetes mellitus (T2DM) in Australia is simi-
lar to European countries at 5%, however a higher inci-
dence is seen in New Zealand (7.3%) and has also been
demonstrated to be much higher in other countries, for
example in Malaysia (17.9%) [3]. Whilst the onset of
T2DM is largely attributed to age and obesity with some
evidence of predisposing genetic risk [4], the aetiology of
T1DM remains unknown. The process through which
pancreatic beta cell destruction occurs is autoimmune
however it is thought to occur in genetically susceptible
individuals and a wide number of hypotheses regarding an
environmental trigger have been studied but not yet
proven [5]. In Australia a higher prevalence of T2DM is
known to be associated with low area socioeconomic
status (SES) [6] and potentially related to higher rates of
obesity. In contrast to T2DM no association with low area
SES has previously been demonstrated for T1DM [7–9].
In Europe, Canada and the United States socioeconomi-
cally disadvantaged people have higher rates of morbidity
and mortality in T1DM [10–14]. However very little is
currently known regarding T1DM prevalence in Australia
and the disease outcome of treated end stage renal disease
(ESRD) due to T1DM for people with low area SES, this
regions Indigenous minority populations, Aboriginal and
Torres Strait Islanders, and Maori and Pacific Islanders.
This study is an exploration of social disparities in diabetes
in relation to area SES and Aboriginal and Torres Strait
Islander, Maori and Pacific Islander ethnicity.
In 2014, there were 25,626 people in Australia and
New Zealand receiving renal replacement therapy for
ESRD, and 37% of new cases (n = 954) were attributed
to diabetic nephropathy [15]. In this region, people with
low area SES are more likely to progress to ESRD due to
kidney disease of any aetiology, but this disparity is most
pronounced in diabetic nephropathy caused by T2DM
[16, 17] with a relative risk of progression to ESRD for
the most disadvantaged decile versus the most advan-
taged decile of 2.38 [17]. While studies from other
countries have found a higher likelihood of ESRD due to
T1DM for people with low SES [18, 19] this has not pre-
viously been studied separately from T2DM in Australia.
The incidence of T1DM in the Aboriginal and Torres
Strait Islander population is reported to be 9 per
100,000 but this may be an underestimate because of
lower levels of registration with the National Diabetes
Services Scheme and underreporting of Indigenous
status at diagnosis [7]. Although the incidence of T1DM
nephropathy has not previously been reported for
Aboriginal and Torres Strait Islanders, Maori and Pacific
Islanders, the incidence of progression to ESRD from
chronic kidney disease in these populations due to any
cause is much higher than the general population [20]. It
is also known that Aboriginal and Torres Strait
Islanders, Maori and Pacific Islanders have a dispropor-
tionate burden of ESRD [15] from diabetic nephropathy,
which is attributed to a higher prevalence of T2DM but
also to an increased likelihood of progressive renal
disease [20]. This has largely been attributed to individ-
ual behaviours [20] however limited access to appropri-




The aims of this study were to examine the population
prevalence of diabetes in Australia for an association
with area SES. This study also sought to determine
whether there is any relationship between T1DM ESRD
and area SES in Australia, and to re-examine diabetic
nephropathy ESRD for this region’s most socially disad-
vantaged and vulnerable minority populations: Aboriginal
and Torres Strait Islanders in Australia, and Maori and
Pacific Islanders in New Zealand.
Study design
This observational study is a secondary analysis of existing
data using an ecological design to make large scale com-
parisons between groups [22]. Ethical approval for the
research was obtained from the Southern Adelaide
Clinical Human Research Ethics Committee (SACHREC),
reference number 564.13.
Study period
This study examined all reported cases of T1DM ESRD
for a 5 year period from 2008 to 2012 and the Australian
population prevalence of diabetes as recorded in 2014.
Data sources
Treated end stage renal disease
The Australia and New Zealand Dialysis and Transplant
Registry (ANZDATA), located within the South Australian
Health and Medical Research Institute, record the inci-
dence and outcomes of dialysis and transplant treatment
for people with ESRD and receive their data annually from
individual Renal units. The information collected by the
ANZDATA Registry is used for research that is of benefit
to the data contributors, a process overseen by a network
of nephrologists, surgeons and renal nurses with interest
and expertise in using the data [23]. Australian population
data and individual-level de-identified data (gender, age,
age of development of ESRD) for all cases of ESRD due to
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T1DM for a five-year period (n = 534) were obtained from
the ANZDATA Registry. Data were also obtained on the
relative risk ratio (RR) for T1DM and T2DM ESRD for
Aboriginal and Torres Strait Islanders and Maori and
Pacific Islanders through an analysis of all data held
in the registry.
Socioeconomic status
The Socio-Economic Indexes for Areas (SEIFA) is an
index developed by the Australian Bureau of Statistics
that ranks areas in Australia according to relative socio-
economic advantage based on information from the
five-yearly Census [24]. The structure of SEIFA allows
measurement of key components of area SES such as in-
come, wealth, social class, occupation, education and
community cohesion and individual data from within a
post code area is aggregated to rank that post code by
area SES. A SEIFA index summarises the characteristics
of people and households within an Australian postal
area. The combination of these measures allows an inte-
gration of the individual, household and community
factors that can influence health [25]. Data in SEIFA are
ranked in deciles from 1 (lowest area SES) to 10 (highest
area SES). ANZDATA records the residential postcode
for each Australian case of ESRD and these post codes
were used to explore population prevalence of diabetes
to estimate the relative risk of ESRD. The postal areas
SEIFA (2011) was used to identify the area SES for each
postcode. The population in each post code ranged from
294 to 102,224 however the median population per post
code was 17,467 people.
The prevalence of diabetes in a sample of the Australian
population
This study examined the population prevalence of dia-
betes in a cross sectional way rather than a whole of
region way using the T1DM ESRD post codes as a sam-
ple. Using the post codes for each case of T1DM ESRD
the total size of the population studied for diabetes
prevalence was 7,434,492 which represents one third of
the Australian population. Population size (number of
people) in each postcode with a case of T1DM ESRD
was recorded, and the population prevalence of diabetes
in that postcode (number of people with diabetes) which
is recorded by the National Diabetes Service Scheme
registrant database was then used to calculate diabetes
prevalence as a percentage. The data were then con-
verted into population prevalence by SEIFA decile using
the Australian Bureau of Statistics database which lists
the SEIFA decile for each postcode. People newly
diagnosed with diabetes register with the National
Diabetes Services Scheme and the register is thought to
have almost complete coverage.
Statistical analysis
The characteristics of the data determined the descriptive
and inferential statistics used through an examination of
normality, distribution and the level of measurement [26].
For the continuous data, Levine’s tests of normality were
used, which have an assumption that the variance between
groups is normally distributed. For normally distributed
data, the parametric t-test was used for independent
variables with two categories, and an analysis of variance
(ANOVA) was used for independent variables with more
than two categories. Where the continuous dependent
variable was not normally distributed and the independent
variable had more than two categories, the non-
parametric Kruskal–Wallis tests and Spearman’s rank cor-
relation coefficients were used [27, 28]. To calculate the
relative risk of T1DM ESRD in relation to area SES the 10
SEIFA deciles were further condensed into two categories
of low area SES (deciles 1–5) and high area SES (deciles
6–10). Relative risk estimates were calculated within a
chi-squared analysis. Data were analysed in SPSS Statistics
for Windows, version 21, IBM Corp., Armonk, NY; IBM
Corp 2012.
Results
Prevalence of diabetes mellitus in the population sample
(2014)
Population prevalence for any form of diabetes was plot-
ted against the SEIFA deciles.1 The mean prevalence of
diabetes was 5.3% (IQR 4.2–6.3, SD 1.63). The preva-
lence of diabetes in the Australian population varies
considerably by SEIFA decile. There was an incremental
increase in prevalence as area SES decreased, with the
lowest SEIFA decile having a prevalence of diabetes
more than double that of the highest decile, demonstrat-
ing an inverse social gradient (Fig. 1). The correlation
coefficient for association between SEIFA decile and the
percentage of the population with diabetes was −.765
(Spearman’s p < 0.001).
Most diabetes cases in Fig. 1 are T2DM (85%) with the
remaining 15% comprising of T1DM (12%) and gesta-
tional diabetes (3%). The outliers seen in Figs. 1 and 2
were included in the analysis. They represent postcodes
(communities) with a much higher or much lower
prevalence than that seen in the decile overall and may
represent familial clustering or a particularly high dens-
ity of a single minority ethnic group, both of which are
known to be associated with diabetes prevalence.
Prevalence of type 1 diabetes mellitus in the population
sample (2014)
In Fig. 2, T1DM data are presented separately to all
other types of diabetes. The mean prevalence of T1DM
was 0.588% of the population (IQR 0.49–0.66, SD 0.161).
The national prevalence of T1DM is known to be 0.5%
Hill et al. BMC Public Health  (2017) 17:802 Page 3 of 8
of the population and previously this has been reported
as not being associated with area SES [29]. The results
show that population prevalence of T1DM in this study
followed a small but statistically significant inverse
gradient with higher area SES deciles having an overall
lower population prevalence of T1DM (Fig. 2).2 The cor-
relation coefficient for association between SEIFA decile
and the percentage of the population with T1DM was
−.397 (Spearman’s p < 0.001).
Type 1 diabetes mellitus treated end stage renal disease
Incidence rates (new presentations) of T1DM ESRD in
Australia are shown in Table 1. Rates have been steadily
increasing but there was a much lower incidence for
people of Aboriginal and Torres Strait Islander ethnicity.
The crude incidence of ESRD due to any cause per
million population was 112 [15] with T1DM represent-
ing about 4.9% of cases in 2012.
Age of presentation with type 1 diabetes mellitus and
end stage renal disease
There was an even distribution of age of onset for inci-
dent T1DM ESRD cases for both males (n = 303) and
females (n = 231). Table 2 describes the incidence rates
of T1DM ESRD during the period studied by age group.
The youngest person diagnosed with T1DM ESRD in
the period was aged 14 years and the oldest was 81 years.
The mean age of presentation was 45 (SD 11.72) and
very few cases were diagnosed after the age of 60 years.
Age of onset of ESRD in T1DM did not differ
significantly by gender (p = .612) however more males
developed T1DM ESRD than females (56.3% versus














Fig. 1 Population prevalence (percentage) of any form of diabetes by collation of the sample post codes ranked into SEIFA deciles from 1 (lowest














Fig. 2 Population prevalence (percentage) of T1DM in Australia by collation of the sample post codes ranked into SEIFA deciles from 1 (lowest
area SES) to 10 (highest area SES) 2014
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Torres Strait Islanders and Maori seen over this period
make a comparison on age of onset between groups
unreliable.
Type 1 diabetes mellitus treated end stage renal disease,
socioeconomic status, age and gender
There were similar numbers of incident cases of T1DM
ESRD in each SEIFA decile from the lowest area SES (1)
through to 9 (range 43–50) with a slightly smaller num-
ber (32) in decile 10, the most advantaged area SES.
There was little difference in age of presentation by area
SES, with the mean age being almost identical between
deciles 1 (47.31) and 10 (47.19). A multivariate one-way
ANOVA demonstrated no significant difference between
the age of presentation in relation to area SES for males
or females (p = .766, p = .289). However, males of low
area SES were overall at increased risk of T1DM ESRD
compared with females of low area SES (RR 1.20, CI
1.002–1.459, p = .043).
Ethnic disparities in type 1 diabetes mellitus and type 2
diabetes mellitus treated end stage renal disease in
aboriginal and Torres Strait islanders, Maori and Pacific
islanders
The number of Aboriginal and Torres Strait Islanders and
Maori and Pacific Islanders with ESRD from T1DM was
very low, whilst the RR for all other Australians and New
Zealanders in comparison to Aboriginal and Torres Strait
Islanders, Maori and Pacific Islanders was 2.99 (CI 2.14–
4.18, p < 0.001) [30]. For ESRD in the setting of T2DM
however the RR was 6.57 for Indigenous Australians
(CI 6.04–7.14, p < 0.001) and 6.48 for Maori and Pacific
Islanders (CI 6.02–6.97, p < 0.001) [30] in comparison to
all other Australians and New Zealanders.
Discussion
Population prevalence of diabetes
The prevalence of diabetes in the Australian population
follows a pronounced inverse social gradient, increasing
incrementally as area SES falls. It was previously re-
ported that the national prevalence of diabetes was 5.4%
and that low area SES was associated with a threefold
higher prevalence of T2DM [6], but the striking and
uniform social gradient demonstrated in this study has
not been described previously. A recent study in
Germany has also demonstrated a social gradient in the
prevalence of diabetes [31] suggesting that this may be a
global phenomenon. Across the Australian population
there was also a statistically significant gradient in
T1DM with the highest incidence also seen in the lowest
area SES. Although the incidence of T1DM shows a
large variation worldwide, environmental or genetic
causation has not yet been determined [32] and this is
the first Australian study to describe an inverse relation-
ship between incidence of T1DM and area SES.
Type 1 diabetes mellitus and treated end stage renal
disease
The mean age of presentation with T1DM ESRD
(45 years) is significantly lower than for other aetiologies
combined (other than paediatric-specific kidney disease)
with the national mean age of presentation with ESRD
being 60 years [33]. There were few T1DM ESRD cases
diagnosed after the age of 60 years, probably because of
higher mortality seen in T1DM [34]. There was an
excess of ESRD for males with T1DM in Australia and
this may be due to several factors. There is an overall
higher incidence of T1DM in males [7], higher cardiac
mortality has been demonstrated for females with
T1DM [35, 36] resulting in death before the develop-
ment of ESRD, a higher risk for males of developing
ESRD regardless of disease aetiology [33] and a bias in
propensity to treat towards males [37]. This study has
also shown an increased risk of ESRD for males of low
area SES. There is considerable evidence for poorer out-
comes in people of low SES with T1DM [10, 14] and of
the higher risk of ESRD for males [38, 39], however no
other studies to date have found an increased risk of
ESRD only for males of low area SES. A recent Swedish
study found that being of low SES increased the risk of
death two- or three-fold, and that males were more
likely to die overall, but this was not explicitly examined
in relation to males of low SES [40]. Health care access
is an important social determinant of health outcomes
in T1DM and Australia offers a Universal ‘free’ health
Table 1 T1DM ESRD incidence rates per million population with
the lower and upper bound values for the period 2008–2012
Year Australia (non-Aboriginal




2008 5.90 (4.69–7.34) 0.26 (0.03–0.95) 6.22 (1.69–15.93)
2009 4.86 (3.77–6.16) 0.51 (0.14–1.33) 6.12 (1.66–15.68)
2010 5.43 (4.29–6.79) 0.63 (0.20–1.48) 3.01 (0.36–10.88)
2011 6.50 (5.25–7.96) 0.12 (0.003–0.69) 5.93 (1.61–15.20)
2012 8.27 (6.85–9.89) 0.36 (0.07–1.06) an/a
ano Maori cases reported for this year
Table 2 T1DM ESRD new cases for the period 2008–2012 classified
by age group
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care service. However people with low SES have lower
levels of health literacy defined as more than literacy
and numeracy to incorporate a degree of difficulty in navi-
gating the health care service irrespective of ‘universal
coverage’ [41]. Australian research is warranted to explore
the higher risk of ESRD for males of low area SES to
determine if it is an adverse outcome or in fact a survival
advantage.
Aboriginal and Torres Strait islanders, Maori and Pacific
islanders
The very low incidence of T1DM ESRD in the Aboriginal
and Torres Strait Islander and Maori populations, in
the face of the extremely high incidence of T2DM
ESRD, is difficult to interpret for a number of
reasons. The issue of survival may be an underlying factor
because there is a well-demonstrated intergenerational
cyclical disadvantage experienced by Indigenous people as
a result of colonisation [42]. Aboriginal and Torres Strait
Islander people have the worst health, lowest life expect-
ancy and highest child mortality rates of all Australians
[43] and death rates due to diabetes, which is generally
reported as T2DM in this population, are 30 times higher
than in other Australians [44]. In addition, there appears
to be no studies of young adult onset T1DM in the
Aboriginal and Torres Strait Islander population despite
Australian data demonstrating that almost 50% of cases of
T1DM are diagnosed after the age of 15 years [1, 8].
Studies conducted overseas suggest that up to 30% of
cases diagnosed as T2DM test positive for autoantibodies
and could be due to T1DM or late onset autoimmune
diabetes in adults (LADA) [45]. This raises a second
possibility, that of misclassification and conflation of
T1DM with T2DM, which could lead to incorrect treat-
ment and earlier death. These findings in relation to
T1DM suggest a need to investigate diabetes classification
in the Aboriginal and Torres Strait Islander population
with autoantibody and C-peptide testing. It is also worth
noting that in regard to the grossly inflated risk of ESRD
due to T2DM in Aboriginal and Torres Strait Islanders,
Maori and Pacific Islanders, these populations also have
the lowest SES, and being an ethnic minority and of low
SES are independently associated with poor outcomes in
diabetes [46].
Study limitations
Reporting of census data to the Australian Bureau of
Statistics who develop the SEIFA categories is mandatory
in Australia. The risk of ecological fallacy is acknowl-
edged when determining individual SES status from area
SES through the assumptions that are made about indi-
viduals based on group data [47]. However, the purpose
of this study is not to determine causation but to make
large scale comparisons between groups [22]. The use of
SEIFA categories has repeatedly demonstrated that
health status is related to socioeconomic status however
cannot identify exactly which aspects of socioeconomic
disadvantage lead to health disadvantage [48]. In
addition there may be status inconsistencies in the
SEIFA SES areas. This study reports a sub-sample of the
Australian population for diabetes prevalence in relation
to SES and a whole of population study would be needed
to be fully conclusive. The association between area SES
and ESRD could be a consequence of people moving to
an area of low SES because of chronic illness and
reduced capacity for income. In addition, there are com-
peting risks for ESRD development in relation to the
high cardiac mortality seen in T1DM. A diagnosis bias
to T2DM for a case of T1DM cannot be excluded when
using registry data and there may be inconsistent classi-
fication of ethnicity for Aboriginal and Torres Strait
Islanders, Maori and Pacific Islanders. Data relating to
prevalence and renal outcomes of T1DM in the Aborigi-
nal and Torres Strait Islander, Maori and Pacific Islander
population is thought to be widely underreported and
insufficient for conclusions to be drawn. The 5 year time
frame used in this study is a limitation and may have im-
pacted on the strength of the results. The data in Table
1 describing the incidence of T1DM ESRD would be
more fully understood with the addition of standardized
rates/reference population however to our knowledge no
such data on T1DM is kept in Australia due to the
absence of a T1DM registry.
Conclusion
This study has demonstrated a uniform inverse social
gradient in diabetes prevalence in Australia confirming
the strong association between socioeconomic disadvan-
tage and the disease. With regard to diabetic nephropa-
thy ESRD whilst it has previously been demonstrated
using ANZDATA that populations in Australia of low
area SES carry a heavier burden of ESRD this study of
T1DM ESRD over a five-year period shows that there
appears to be an increased risk only for males of low
area SES. ESRD may not be the most suitable measure
of disproportionate outcomes in T1DM in Australia
given that a high mortality from the disease for people
of low SES before reaching ESRD is likely. Other
countries have reported an inverse relationship between
SES and mortality in T1DM [10–14] with a much higher
likelihood of death for people who are socioeconomically
disadvantaged and this disparity is more pronounced in
T1DM than in T2DM [49]. For this reason, it remains
uncertain whether this study demonstrates an increased
risk for males or a survival advantage. While there are
doubts about classification of diabetes in the Aboriginal
and Torres Strait Islander population, the grossly in-
flated risk of diabetic nephropathy ESRD for Aboriginal
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and Torres Strait Islanders, Maori and Pacific Islanders
over the time period studied is a shared disparate out-
come across these three minority populations that has
changed little in the past 20 years.
Endnotes
1Data are presented in box and whisker plots with out-
liers (extreme cases in each decile) represented by the
symbols °* which denote individual postcodes.
2The postcode with zero prevalence seen in decile 1
(lowest area SES) in Fig. 2 is a remote area and may
represent lack of services and/or registration with the
National Diabetes Services Scheme.
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